SCHEMBL2393986

SCHEMBL2393986

[c]1occ2cncnc12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20483 0.64 EGFR (0.47)
SCHEMBL4054789 0.64 EGFR (0.37)
SCHEMBL3935658 0.62 EGFR (0.35)
SCHEMBL8311252 0.60 EGFR (0.38)
SCHEMBL3934464 0.60 EGFR (0.38)
SCHEMBL29809882 0.59 EGFR (0.46)
SCHEMBL140301 0.59 EGFR (0.46)
SCHEMBL2035779 0.59
SCHEMBL17511920 0.59 EGFR (0.46)
SCHEMBL10932285 0.58

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2719701-A1 methods for the preparation of thieno[3,4-d]pyrimidin-7-yl ribosides GILEAD SCIENCES, INC. (US) 2014-04-16 EP disclosed
CN-102348713-A CARBA-nucleoside analogs for antiviral treatment GILEAD SCIENCES INC 2012-02-08 CN disclosed
EP-2396340-A1 CARBA-NUCLEOSIDE ANALOGS FOR ANTIVIRAL TREATMENT Gilead Sciences, Inc. (US) 2011-12-21 EP disclosed
US-8012942-B2 Carba-nucleoside analogs for antiviral treatment GILEAD SCIENCES, INC. (US) 2011-09-06 US disclosed
WO-2010093608-A1 CARBA-NUCLEOSIDE ANALOGS FOR ANTIVIRAL TREATMENT GILEAD SCIENCES, INC. (US) 2010-08-19 WO disclosed
US-20100203015-A1 CARBA-NUCLEOSIDE ANALOGS FOR ANTIVIRAL TREATMENT GILEAD SCIENCES, INC. (US) 2010-08-12 US disclosed